BioSpace News Archive

Axovant Gene Therapies, Ltd. (NASDAQ: AXGT), a clinical-stage company developing innovative gene therapies, today announced upcoming presentations regarding its investigational gene therapy programs, AXO-Lenti-PD, AXO-AAV-GM1 and AXO-AAV-GM2, at the European Society of Gene and Cell Therapy (ESGCT) 27th Annual Congress, held in Barcelona, Spain, October 22-25, 2019.

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep“ or “the Company“), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, today announced that clinical data on the Company’s lead product candidate eftilagimod alpha (“efti” or “IMP321”), a soluble LAG-3Ig fusion protein based on the LAG-3 immune control mechanism, will be presented at two industry conferences in October and November 2019.

SiteOne Therapeutics, a privately-held biopharmaceutical company advancing novel non-opioid pain therapeutics, today announced that it has received a Notice of Award from the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH

Discovery Behavioral Health, a leading nationwide provider of behavioral health services, has opened a new facility in Temecula, CA, located in Riverside County outside of Los Angeles.

Incyte Corporation announced that it has scheduled its third quarter 2019 financial results conference call and webcast for 8:00 a.m. ET on Tuesday, October 29, 2019.

Emerging bio companies and researchers are selected to present, showcasing leading thought in bioscience innovation at Oregon Bio 2019: Innovating and Scaling for our Region’s Growth – the conference created for investors, start-up entrepreneurs, executives, researchers and policymakers, happening Oct. 29 in Portland. #OregonBio2019

Despite being world leaders in cannabis, American cannabis businesses and investors’ profits are suffering due to the strict federal laws that specifically prohibit them exporting cannabis to Europe and Canada, both of which are prospering due to the changing laws and stances on medical cannabis.

AgraFlora Organics International Inc. applauds its exclusive CBD sports partner, the Toronto Wolfpack RLFC’s promotion to the 2020 RLF Super League competition; an accomplishment that positions the TWP in the highest tier of English rugby league, boasting international broadcast reach to over 250,000,000 homes.

Innovent Biologics, Inc. and Hutchison China MediTech Limited announced the expansion of their global collaboration agreement to evaluate the safety and efficacy of Innovent’s Tyvyt®

As part of the multi-target collaboration Avacta will generate and optimise Affimer binders against three undisclosed cancer targets and provide these to ADC Therapeutics to target its proprietary cytotoxic warheads to the site of the tumour.